Researchers have categorized the cells into different classes based on their functionality and appearance. The cells have shown to possess different actions and view under the microscope. The basic concept of the current study is to find a unique visual difference in the behavior of the genes. According to the researchers from the Johns Hopkins Institute for Genetic Medicine, the Johns Hopkins Department of Neuroscience, and the Johns Hopkins Kimmel Cancer Center, they have created two novel deep learning methods in order to decode the tangled gene activity that controls a cell fate decision in retina formation and also link the same gene activity with the nearby tissues in different species. The current study focuses on the differences and similarities in the cellular function that could provide an insight into the cells for developing a better treatment.
The retina was the chosen model system as it mirrored the development of the entire brain, however with certain limitations in the cell types. The new single cell sequencing technology derived data was used by the researchers to know about the specific genes activated among the 120,000 individual cells present in the retina. The use of two diverse artificial intelligence programs like the scCoGAPS and projectR helped first classify cells based on the expression levels and second helped relate the developing cells with the other cells in the retina. The researchers found some similarities in the developing and postnatal cells expressing patterns in the developing cells that were different from them mature cells.
The use of CoGAPS helped spot the alterations in the gene expression and cell cycle that caused the progenitors to form a different cell type. The researchers could compare the developmental alterations between different species or organ systems. The scientists could picture the complex gene activity using scCoGAPS and projectR and in turn, find better targets for cancers. Washington State University researchers have provided the government regulators a tool to check the commercial claims and risks surrounding hemp, non-medical marijuana, and CBD products become thoroughly. The new technique analyses genetic and chemical characteristics of cannabis during the examination.